Semaglutide, also known as Ozempic or Wegovy, is set to transform treatments for cardiovascular disease, but a change in ...
A groundbreaking study has revealed that an anti-obesity jab containing semaglutide, a drug used to treat obesity, significantly reduces the risk of heart attacks and strokes, regardless of the amount ...
Injections of a weight loss drug could be a ‘game changer’ for cardiovascular patients by cutting the risk of heart attacks or strokes.
Trials of a weight-loss drug which could cut the risk of heart attacks and strokes by a fifth feature heavily as a range of stories compete for attention on Tuesday’s newspaper front pages. The Times ...